Vyome Holdings, Inc

HINDSEC EDGAR

Pharmaceutical Preparations(DE)CIK: 1427570

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue from Contract with Customer, Excluding Assessed Tax	$8.7M	$11.2M	$13.6M	$11.3M	$3.3M
Cost of Goods and Services Sold	$3.1M	$4.4M	$5.3M	$5.0M	$3.0M
Gross Profit	$5.5M	$6.8M	$8.3M	$6.3M	$331.0K
Research and Development Expense	$2.3M	$2.5M	$2.1M	$3.5M	$6.9M
Selling, General and Administrative Expense	—	$14.1M	$5.9M	$4.7M	$16.7M
Operating Expenses	$20.9M	$53.2M	$10.4M	$18.7M	$23.6M
Operating Income (Loss)	-$15.4M	-$46.4M	-$5.9M	-$12.5M

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Assets	$10.7M	$11.1M	$120.0M	$37.1M	$20.4M
Assets, Current	$10.3M	$9.9M	$65.3M	$8.9M	$18.2M
Cash and Cash Equivalents, at Carrying Value	$4.5M	$3.9M	$22.8M	$3.0M	$14.1M
Accounts Receivable, after Allowance for Credit Loss, Current	$1.0M	$1.7M	—	—	$285.0K
Inventory, Net	$3.7M	$3.6M	$3.0M	$2.2M	$1.9M
Liabilities	$4.0M	$7.5M	$8.2M	$22.6M	$4.5M
Liabilities, Current	$3.8M	$7.5M	$7.5M	$11.6M	$4.0M

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Net Cash Provided by (Used in) Operating Activities	-$17.0M	-$21.9M	-$15.4M	-$8.6M	-$22.9M
Net Cash Provided by (Used in) Investing Activities	-$10.0K	-$92.0K	$1.9M	-$2.4M	$2.4M
Net Cash Provided by (Used in) Financing Activities	$17.6M	$3.1M	$33.3M	$11.1M	$13.4M
Payments to Acquire Property, Plant, and Equipment	—	—	—	—	$194.0K

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)